Morgan Stanley’s TuHURA Biosciences, Inc. Common Stock HURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.1K | Buy |
34,121
+22,298
| +189% | +$49.7K | ﹤0.01% | 6222 |
|
|
2025
Q1 | $38.2K | Buy |
11,823
+6,985
| +144% | +$22.6K | ﹤0.01% | 6367 |
|
|
2024
Q4 | $19.8K | Buy |
4,838
+4,825
| +37,115% | +$19.7K | ﹤0.01% | 6575 |
|
|
2024
Q3 | $88 | Buy |
+13
| New | +$88 | ﹤0.01% | 7462 |
|
|
2023
Q4 | – | Sell |
-96
| Closed | -$13.5K | – | 7921 |
|
|
2023
Q3 | $13.5K | Hold |
96
| – | – | ﹤0.01% | 6614 |
|
|
2023
Q2 | $13.5K | Hold |
96
| – | – | ﹤0.01% | 6699 |
|
|
2023
Q1 | $11.8K | Sell |
96
-25
| -21% | -$3.08K | ﹤0.01% | 6826 |
|
|
2022
Q4 | $29.3K | Buy |
121
+120
| +12,000% | +$29.1K | ﹤0.01% | 6528 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 7914 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | -$2K | – | 8015 |
|
|
2022
Q1 | $2K | Sell |
3
-2
| -40% | -$1.33K | ﹤0.01% | 7767 |
|
|
2021
Q4 | $4K | Buy |
5
+2
| +67% | +$1.6K | ﹤0.01% | 7701 |
|
|
2021
Q3 | $5K | Hold |
3
| – | – | ﹤0.01% | 7503 |
|
|
2021
Q2 | $13K | Hold |
3
| – | – | ﹤0.01% | 7161 |
|
|
2021
Q1 | $10K | Buy |
+3
| New | +$10K | ﹤0.01% | 6948 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7133 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6849 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6751 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6735 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6791 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6779 |
|
|
2019
Q2 | – | Hold |
0
| – | -$1K | – | 6768 |
|
|
2019
Q1 | – | Hold |
0
| – | -$1K | – | 6545 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6531 |
|